Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism
Public ClinicalTrials.gov record NCT02504541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Month Safety Study of QuickShot™ Testosterone Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Study identification
- NCT ID
- NCT02504541
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Antares Pharma Inc.
- Industry
- Enrollment
- 133 participants
Conditions and interventions
Conditions
Interventions
- Testosterone enanthate auto-injector Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- May 31, 2016
- Completion
- May 31, 2016
- Last update posted
- Mar 29, 2018
2015 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Aventura | Florida | — | — |
| Not listed | Brandon | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Elkridge | Maryland | — | — |
| Not listed | Garden City | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Franklin | Ohio | — | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Hurst | Texas | — | — |
| Not listed | West Valley City | Utah | — | — |
| Not listed | Olympia | Washington | — | — |
| Not listed | Renton | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02504541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02504541 live on ClinicalTrials.gov.